Krishna Institute of Medical Sciences Limited has made a regulatory disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding its schedule of analyst and institutional investor meetings.
The company disclosed details of a proposed Analyst/Institutional Investor Meeting scheduled for November 16, 2026. The meeting will be held as part of the JM Financial Annual India Conference in Mumbai, India, and is classified as a Group Meeting.
The disclosure explicitly states that no Unpublished Price Sensitive Information will be shared during the meeting. The company also noted that the schedule is subject to change due to any exigencies that may arise.
The disclosure was signed by Nagajayanthi J.R, Company Secretary & Compliance Officer, and was addressed to both the Bombay Stock Exchange Ltd (BSE) and the National Stock Exchange (NSE) of India.
Financial Impact
No financial impact disclosed. This is an informational disclosure about scheduled investor relations activities.